Table 3.
Univariate and multivariate survival analysis of prognostic factors for patients with SCC.
| Factors | Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|---|
| n | χ 2 | p | β | SE | Wald χ2 | HR (95% CI) | p | |
| Age | 0.993 | 0.319 | ||||||
| ≤59 | 64 | - | - | - | - | |||
| 60 | 143 | |||||||
| Tumor differentiation | 2.380 | 0.123 | - | - | - | - | ||
| Moderate, well | 187 | |||||||
| Poor | 20 | 0.471 | 0.459 | 1.052 | 1.602 (0.651–3.940) | 0.305 | ||
| Tumor stage | 3.622 | 0.057 | ||||||
| I, II | 124 | - | - | - | - | |||
| III | 83 | 1.442 | 0.596 | 5.859 | 4.228 (1.316–13.586) | 0.015 | ||
| Lymph node metastasis | 0.04 | 0.834 | ||||||
| No | 125 | - | - | - | - | |||
| Yes | 82 | −0.829 | 0.606 | 1.871 | 0.436 (0.133–1.432) | 0.171 | ||
| Adjuvant chemotherapy | 32.410 | <0.001 | ||||||
| No | 111 | - | - | - | - | |||
| Yes | 96 | −1.360 | 0.392 | 12.044 | 0.257 (0.119–0.553) | 0.001 | ||
| SRA preservation | 0.606 | 0.436 | ||||||
| No | 123 | - | - | - | - | |||
| Yes | 84 | 0.510 | 0.336 | 2.303 | 1.665 (0.862–3.218) | 0.129 | ||